2011 Volume 37

Advisory Committee Statements and Supplements to the CCDR

• An Advisory Committee Statement (ACS) - Recommendations on the use of MF59-Adjuvanted Trivalent Influenza Vaccine (Fluad^®): Supplemental Statement of Seasonal Influenza Vaccine for 2011-2012 ACS- 6, October 2011
• An Advisory Committee Statement (ACS) - Statement on Seasonal Influenza Vaccine for 2011–2012 ACS- 5, October 2011
• An Advisory Committee Statement (ACS) - Addendum to the 2010-2011 Seasonal Trivalent Inactivated Influenza Vaccine ACS- 4, September 2011
• An Advisory Committee Statement (ACS) - Fever in the Returning International Traveller ACS- 3, July 2011
• An Advisory Committee Statement (ACS) - Statement on Older Travellers ACS- 2, July 2011
• An Advisory Committee Statement (ACS) - Statement on Protection Against Japanese Encephalitis ACS- 1, April 2011

---

• Supplement:
  A Tool for the Potential Fall 2009 Wave of Pandemic H1N1 to Guide Public Health Decision-Making: An Overview of the Public Health Agency of Canada’s Planning Considerations, September 2009 CCDR Volume 37s1, January 2011

---

• Information on how to download PDF files
• Canada Communicable Disease Report Masthead
• Guidelines for Authors Contributing to the CCDR
• CCDR Author's Checklist